Molecular mechanisms of GI Tumor cell reprogramming governed by lactate metabolism
Molecular mechanisms of GI Tumor cell reprogramming governed by lactate metabolism
批准号:
398809650
负责人:
Professor Dr. Heiner Schäfer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Representing an important determinant of the cellular phenotype, cell metabolism has an essential role in tumorigenesis, A particular condition that greatly impacts on phenotype manifestation and clonal diversity is the metabolic compartmentalization and symbiosis that characterizes the ecosystem and heterogeneity in many soild and stroma-rich tumors (including pancreatic and colorectal cancer). This is controlled by extrinsic effectors like glucose and oxygen supply or by oxidative stress involving mediating transcription factors such as HIF1α, Nrf2 and ATF3. An important manifestation of metabolic compartmentalization/ symbiosis is the aerobe-glycolytic (Warburg) metabolism and the lactate dependent/OxPhos (reverse Warburg) metabolism. Here, not only biomass and energy is transferred bewteen distinct cell types, but also metabolites exerting fundamental effects on the cellular phenotype. This mainly includes direct effects on histone- and DNA-modifications, thereby greatly affecting the epigenome. Depending on these alterations, cellular traits manifest that contribute to tumor malignancy (such as resistance, metastasis formation) and that particulary favour the emergence of clonal entities with stem cell-like properties or a phenotype of cellular dormancy. Given the fact that the reverse Warburg metabolism associates with the advancement and poor prognosis in many types of solid tumors, a better understanding of these metabolite mediated effects is certainly of great relevance. The present project therefore aims at elucidating the modalities and cellular events relating to the reverse Warburg metabolism in colorectal and pancreatic cancer. The working plan will address the following issues: 1) By means of cell culture based models the association between reverse Warburg metabolites, epigenome and phenotype alterations will be elucidated; 2.) Immunohistochemical analyses of tumor tissues from pancreatic (PDAC)- and colorectal cancer (CRC) patients will validate the clinico-pathological role of the reverse Warburg metabolism; 3.) Employing the Pdx1-Flp;FSF-KrasG12D/+;Trp53frt/+ (KPF) PDAC-mouse model, which particularly allows the assessment of desmoplastic mechanisms and the temporal tumorigenesis sequence, the impact of the reverse Warburg metabolism on pancreatic carcinogenesis and metastasis will be studied in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanismen proteasomaler Genexpression und erhöhter Proteasomaktivität beim kolorektalen Karzinom
-
批准号:174286018
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Heiner Schäfer
-
依托单位:
Molekulare Mechanismen NFkappaB abhängiger Resistenz von Pankreaskarzinomzellen gegenüber Topoisomeraseinhibitoren
-
批准号:5311326
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Heiner Schäfer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位: